Migraine Clinical Trials in San Antonio

Showing 21-40 of 46 trials

Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy

NCT00632385

To assess the efficacy and safety of eletriptan for migraine headaches in subjects who were not satisfied with rizatriptan therapy

Migraine

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.127 participantsStarted Jan 2003

Irvine, California, United States • Newport Beach, California, United States • San Francisco, California, United States +13 more locations

COMPLETEDPHASE3< 1 mile

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

NCT02873221

This study will evaluate the long-term safety and tolerability of intermittent treatment with ubrogepant for the acute treatment of migraine over 1 year.

Migraine, With or Without Aura

Allergan1,254 participantsStarted Sep 2016

Birmingham, Alabama, United States • Chandler, Arizona, United States • Mesa, Arizona, United States +174 more locations

Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

Migraine Trials in Other Cities

Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention

Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine

Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents

A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)

Zomig - Treatment of Acute Migraine Headache in Adolescents

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention

Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine

Study in Participants With Acute Migraines Headaches

A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache

A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)

A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)

ESCAPE Migraine Trial

Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches

Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine

A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura

Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura

A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine

Other Conditions in San Antonio